PN FeatureFor advertising call PN Sales on 020 7564 2121

compiled by n John Clarkson

PN
HEALTHYLIVINGNEWS

 

On a wing and a prayer

doctor in pray position
Praying for seriously ill patients does not improve their chances of survival, a new study has shown. The MANTRA II study recruited over 700 patients undergoing heart surgery. A total of 371 were assigned off-site prayer teams that included Christian, Muslim, Jewish and Buddhist groups, with the remainder having no prayer group. The investigators, whose findings are published in medical journal The Lancet, found no measurable treatment effect on major adverse cardiovascular events, hospital readmission or death.
In addition, half of the patients were also assigned to Music, Imagery and Touch Therapy (MIT), which involved teaching the patients breathing techniques and playing relaxing music. These patients showed a slightly lower mortality rate after six months.
An accompanying editorial said: “The contribution that hope and belief make to a personal understanding of illness cannot be dismissed so lightly. They are proper subjects for science, even while transcending its known bounds.”


Pomegranates for prostates
 horizontal section of a PomegranateResearch presented to the American Urological Association suggests drinking pomegranate juice slows the rise of prostate specific antigen (PSA) levels by half in men with recurrent prostate cancer. Pomegranate juice contains antioxidants thought to have anti-cancer effects and estrogen-like plant substances called phytoestrogens that could also be effective against prostate cancer. Encouraging results in cell culture prompted researchers at the University of California to conduct a clinical trial of pomegranate juice in 48 men with rising PSA levels after treatment for their malignancy. The average PSA doubling time, a measure of tumour activity, is normally 15 months but was shown to have increased to 37 months among those who received pomegranate juice. Urine testing confirmed the presence of pomegranate antioxidants in all men. A phase three randomized trial is now planned. Men with prostate problems should always inform their doctor if they are taking complementary treatments, such as saw palmetto or pomegranate, as they can affect the outcome of clinical tests.


Bitter pill sweetened

Most vitamins and mineral supplements taken by people living with HIV will not be banned in the UK under new EU rules that came into force on 1 August under a wave of protest. Many HIV positive people feared supplements like selenium and zinc would become unobtainable under the Food Supplements Directive (FSD), a regulation to prevent the sales of potentially harmful ingredients in Europe. Around 20 million people in Britain take vitamins and supplements, spending over £300m a year. Fear that many popular supplements on UK shelves would be outlawed prompted a petition of more than one million signatures in Britain, and a letter of protest to Tony Blair. Under the directive, only ingredients deemed safe and appearing on the EU’s ‘positive list’ will be legal. The Alliance for Natural Health, set up in 2002 to contest the FSD, was pleased with the outcome. In a statement it said: “The fact that requirements for admission to the positive list have been fundamentally changed now means the majority of high quality vitamin and mineral supplements will not face a ban.” Here’s a rough guide to how the FSD will affect availability:
• 99 per cent of supplements will remain unchanged.
•‘Naturally’ occurring forms of vitamins and minerals normally found in the diet will not be affected.
• Products containing as yet unapproved ingredients will remain on sale unless existing evidence points to danger.
• Herbal supplements such as ginseng and St. John’s Wort were never included in the regulations so remain unaffected.
• So-called ‘high-potency’ supplements will also remain available.

 

back to contents - Issue 115

back to top of page

Skip Links